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Herpesvirus infection reorganizes components of the nuclear lamina usually without loss of integrity of
the nuclear membranes. We report that wild-type HSV infection can cause dissolution of the nuclear
envelope in transformed mouse embryonic ﬁbroblasts that do not express torsinA. Nuclear envelope
breakdown is accompanied by an eight-fold inhibition of virus replication. Breakdown of the membrane
is much more limited during infection with viruses that lack the gB and gH genes, suggesting that
breakdown involves factors that promote fusion at the nuclear membrane. Nuclear envelope breakdown
is also inhibited during infection with virus that does not express UL34, but is enhanced when the US3
gene is deleted, suggesting that envelope breakdown may be enhanced by nuclear lamina disruption.
Nuclear envelope breakdown cannot compensate for deletion of the UL34 gene suggesting that mixing of
nuclear and cytoplasmic contents is insufﬁcient to bypass loss of the normal nuclear egress pathway.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Herpesviruses morphogenesis starts in the nucleus by forma-
tion of DNA-ﬁlled capsids and is ﬁnalized in the cytoplasm where
capsids acquire the tegument proteins and the ﬁnal envelope. The
primary mechanism for nuclear egress is an envelopment/de-
envelopment process. Capsids leave the nucleus by budding into
the INM (primary envelopment), which results in formation of
enveloped virions inside the perinuclear space. These so-called
primary virions then quickly resolve by fusing with the outer
nuclear membrane (ONM) (de-envelopment) (Johnson and Baines,
2011; Roller, 2008). Several viral proteins are involved in envelop-
ment/de-development at the NE. HSV-1 pUL34 and pUL31, form a
complex at the INM (Reynolds et al., 2001,, 2002). The alphaher-
pesviral pUL34/pUL31 complex has a multifunctional role during
nuclear egress including lamina disruption (Bjerke and Roller,
2006; Leach et al., 2007; Mou et al., 2007; Park and Baines,
2006; Simpson-Holley et al., 2005) and wrapping the INM around
the capsid (Klupp et al., 2007; Roller et al., 2010, 2011).
De-envelopment of primary virions is facilitated by the pUS3
serine/threonine kinase and this function appears to be conserved
within the alphaherpesviruses (Klupp et al., 2001; Mou et al.,
2009; Reynolds et al., 2002; Ryckman and Roller, 2004;
Schumacher et al., 2005). In HSV-1, the two glycoproteins gB and
gH also participate in de-envelopment. Double deletion of gB and
gH results in accumulation of primary virions inside a dilated
perinuclear space (Farnsworth et al., 2007; Wisner et al., 2009;
Wright et al., 2009). The fusogenic activity of gB is required for its
de-envelopment function since mutations that interfere with gB
fusion activity also interfere with de-envelopment when gH is also
absent (Wright et al., 2009). pUS3 presumably has a regulatory
role in de-envelopment that, in HSV-1, includes regulating the
fusogenic activity of gB (Wisner et al., 2009). Interestingly, de-
envelopment fusion in infection with the related alphaherpesvirus
PrV does not require gB and/or gH, since single and double
deletions egress from the nucleus as efﬁciently as wild-type virus,
and accumulation of perinuclear virions is not observed (Klupp
et al., 2008).
Alphaherpesvirus deletion recombinants that fail to express
either of pUL31 or pUL34 still exhibit low levels of replication,
suggesting that they can egress from the nucleus by a mechanism
independent of pUL34 and pUL31 (Chang et al., 1997; Fuchs et al.,
2002; Klupp et al., 2000; Roller et al., 2000). Furthermore, the
requirement in HSV-1 for UL31 expression in nuclear egress is
apparently cell-speciﬁc, indicating that that there is a nuclear
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egress mechanism that does not rely on the pUL31/pUL34 complex
(Liang et al., 2004). Extensive passage of UL31 or UL34-null PrV
recombinants resulted in variants (called ΔUL31Pass and ΔUL34-
pass) that produced virus at titers similar to the wild type PrV
(Grimm et al., 2012; Klupp et al., 2011). Both viruses caused
nuclear envelope breakdown (NEBD) in infected cells. The obser-
vation was quite striking since normally during herpesvirus infec-
tion the NE appears intact despite drastic changes in nuclear
architecture that include chromatin marginalization, phosphoryla-
tion of the lamina components and expansion of the nucleus
(Bjerke and Roller, 2006; Camozzi et al., 2008; Hamirally et al.,
2009; Leach et al., 2007; Leach and Roller, 2010; Milbradt et al.,
2007; Morris et al., 2007; Mou et al., 2007; Muranyi et al., 2002;
Park and Baines, 2006; Reynolds et al., 2004; Scott and O’Hare,
2001; Simpson-Holley et al., 2004, 2005). Although the mechan-
isms by which ΔUL31pass or ΔUL34Pass induced NE breakdown
are not known, these studies imply that breakdown might provide
an alternative pathway to envelopment/de-envelopment for cap-
sids to exit the nucleus.
The TOR1A gene encodes TorsinA, a member of the AAAþ
ATPase superfamily of proteins that perform diverse cellular
activities (Ozelius et al., 1997; White and Lauring, 2007). TorsinA
is a widely expressed, peripheral membrane protein (i.e., having
no transmembrane domain) localized in the lumen of the ER and
in the space between the inner and outer nuclear membranes
(Callan et al., 2007; Jungwirth et al., 2010; Kustedjo et al., 2000;
Vander Heyden et al., 2011). The TorsinA mRNA encodes a
polypeptide of 332 amino acids with a cleaved signal sequence
that is thought to form hexamers in the ER lumen. Mutation in the
TOR1A gene that leads to a loss of a single glutamic acid residue,
Glu302 or Glu303 near the C-terminus of TorsinA (called the ΔE
mutation) is associated with dominantly-inherited early-onset
torsion dystonia (Ozelius et al., 1997) and reviewed in (Granata
et al., 2009; Granata and Warner, 2010). Several functions, includ-
ing a role as a molecular chaperone and a homeostatic regulator of
an induced ER stress response have been suggested for TorsinA,
and chaperone activity has been demonstrated in vitro (Burdette
et al., 2010; Caldwell et al., 2003; Chen et al., 2010; Hewett et al.,
2003; Hewett et al., 2007; McLean et al., 2002). Although TorsinA
is ubiquitously expressed, pathology is limited to neuronal cells
and in transgenic mice with defects in TorsinA expression or
function that pathology is accompanied by changes in the archi-
tecture of the nuclear envelope including loss of proper spacing
between the INM and the ONM and formation of intranuclear
membrane inclusions (Gonzalez-Alegre and Paulson, 2004;
Goodchild et al., 2005; Jungwirth et al., 2010; Kustedjo et al.,
2000). TorsinA has been found to interact with other host cell
proteins that may participate in its function in maintenance of NE
architecture, including LAP1 and nesprin 3A (Goodchild and Dauer,
2005; Naismith et al., 2009; Nery et al., 2008).
Overexpression of wild-type torsinA (TA), but not a dominant
negative mutant form, impaired herpes simplex virus type 1
(HSV-1) replication and caused a defect in capsid nuclear egress
(Maric et al., 2011). To continue our studies on importance of
TorsinA for HSV-1 we used transformed wild-type and Tor1a /
mouse embryonic ﬁbroblasts (MEFs). We show here that wild type
HSV-1 can induce NEBD in Tor1a / mouse embryonic ﬁbroblast
cell line that is morphologically highly similar to that seen in
infection with mutant PrV. This demonstrates that, in some host
cell environments, extensive NEBD is one possible consequence of
a wild-type virus infection. We have used recombinant mutant
viruses to explore the mechanism of NEBD and ﬁnd that it is
strongly enhanced by UL34 expression and by expression of the
HSV glycoproteins gH and gB that have been implicated in de-
envelopment fusion during nuclear egress.
Results
HSV-1 replication is impaired in transformed Tor1a / MEFs
We previously showed that overexpression of TA inhibits
HSV-1 production in two different cell lines (Maric et al., 2011).
As part of an effort to determine whether TA expression was
necessary for efﬁcient HSV-1 replication, we tested viral single-
step growth on transformed MEFs from Tor1a/ and Tor1aþ /þ
mouse embryos (Fig. 1). Viral yields in Tor1a / MEFs were
signiﬁcantly lower at 12–24 h.p.i. (12 (po0.003), 16 (po0.008)
and 24 (po0.018) h.p.i.) in comparison to Tor1aþ /þ MEFs. At 12 h.
p.i. virus production was more than 8-fold less efﬁcient in
Tor1a/ than in Tor1aþ /þ MEFs. At later times during infection
the difference in HSV-1 replication decreased to about than 3-fold.
HSV-1 infection induces NE breakdown in transformed
Tor1a / MEFs
Since TorsinA is a NE and ER-resident protein, we asked if its
loss interferes with HSV-1 morphogenesis. To ensure that events
prior to capsid assembly are unaffected by TorsinA loss, Tor1aþ /þ
and Tor1a/ MEFs were infected with HSV-1(F) at an MOI of
5 and at 12 h.p.i. accumulation of late (VP5 and pUL34), true late
gene products (pUS11, gC) and processing of viral glycoproteins
(gC, gD, gB) were analyzed by immunoblotting (Fig. 2A). Both cells
lines supported accumulation and processing of viral proteins to
similar extent, indicating that absence of TorsinA does not inter-
fere with early events in virus life cycle (entry, gene expression,
and replication). The impairment in HSV-1 replication is thus
likely associated with capsid assembly and/or subsequent events.
To examine the defects in TorsinA-null MEFs, mock- or HSV-1(F)-
infected Tor1aþ /þ and Tor1a/ MEFs were examined by TEM
(Fig. 2B). All stages of virus assembly were observed in both MEF
cell lines and the quantiﬁcation of virus particles in 10 randomly
selected cell sections is provided in Table 1. About 3 fold fewer virus
particles were counted in Tor1a/ in comparison to Tor1aþ /þ MEFs
and this reduction was correlated with fewer capsids found in the
nucleus and the cytoplasm of Tor1a/ MEFs. While quantitative
measurement of capsid production is uncertain in analysis of EM, due
to the low number of cells examined, these results suggest the
possibility of a defect in assembly and/or stability of capsids in
Tor1a / MEFs, which might explain the lower virus titer in these
cells. Ultrastructural analysis also revealed breakdown of the NE in
Fig. 1. HSV-1 replication is inhibited in transformed Tor1a/ MEFs. Single-step
growth kinetics of HSV-1 were measured on TA MEFs. Tor1aþ /þ and Tor1a/ MEFs
were infected with HSV-1(F) at an MOI of 5 and at indicated points virus infectivity
of whole cell cultures was determined by plaque assay on Vero cells. Points plotted
are the mean of three independent experiments; error bars represent the standard
deviation. The difference in infectivity at 2 h.p.i. reﬂects differences in the amount
of residual infectivity left from the inoculum after washes in citrate buffer.
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HSV-1 infected Tor1a / MEFs (Fig. 2Bc and d). In 3 out of 10
examined cell sections between 0.25 and 1 mm long perforations at
the NE were observed (Fig. 2Bc white arrows). These perforations
were even larger in an additional 4 out of 10 cell sections where
substantial areas of cells without NE were observed and borders
between the nucleus and the cytoplasm were diminished (Fig. 2Bd).
Instead of NE, tubular or cisternal structures ranging in length from
0.2 to 2 mm were observed suggesting vesicularization of the NE
(Fig. 2Bc and d black arrowheads). The NE of uninfected Tor1a /
cells is intact and without blebs due to compensatory effect of torsinB
(Fig. 2Ba), as shown previously (Jungwirth et al., 2010). The NE in 10
randomly selected infected Tor1aþ /þ MEF cell sections was intact
Fig. 2. HSV-1-induced nuclear envelope breakdown in Tor1a/ MEFs. (A) Accumulation and processing of viral proteins in TA MEFs. Tor1aþ /þ and Tor1a / MEFs were
infected with HSV-1(F) at an MOI of 5 and 12 h later, whole cell lysates were subject to immunoblot analysis with antibodies to proteins indicated on left. Blots shown are
representative of three experiments. (B) Ultrastructural analyses of TA MEFs. Shown are micrographs of Tor1aþ /þ (b) and Tor1a/ (a, c, and d) MEFs infected with mock
(a) or HSV-1(F) at an MOI of 10 (b, c, and d) and 20 h later ﬁxed and processed for TEM. The scale in μm is indicated at the lower left of each panel and is the same for all
panels. In (b) white arrowheads point to NE perforations which likely represent the NPC. White arrows in (c) indicate large NE breaks and black arrowhead in (c, d) point to
tubular membranous structures in place of the NE.
Table 1
Quantiﬁcation of virus particles in HSV-1(F) infected Tor1aþ /þ and Tor1a / MEFs.a
No. (%) of cytoplasmic virus particles
No. (%) of nuclear capsids No. (%) of perinuclear virions Naked capsids Enveloped virions No. (%) of surface virions Total no. (%) of counted particles
Tor1aþ /þ 867 (68.1) 5 (0.4) 181 (14.2) 184 (14.4) 37 (2.9) 1274 (100)
Tor1a / 307* (66.2) 11 (2.4) 58 (12.5) 81 (17.5) 7 (1.5) 464 (100)
a TEM images of ten randomly selected cells with at least one capsid or margination of chromatin were taken and subsequently counted for virus particles.
n In cases where boundaries between the nucleus and cytoplasm were diminished due to NE breakdown capsids were counted as nuclear when no obvious cytoplasmic
structures were visible in capsids proximity.
M. Maric et al. / Virology 460-461 (2014) 128–137130
with occasional small perforations (less than 0.1 mm) that most likely
represent the nuclear pore complex (NPC) (Fig. 2Bb white
arrowheads).
TorsinA independence in NEBD
We used several approaches to determine whether the NEBD
phenotype observed in transformed Tor1a / MEFs was due to the
absence of TA expression, including testing for the phenotype in
fresh primary Tor1a / MEFs and in MEFs in which TA expression
was restored by stable transfection of a TA expression construct.
We did not observe NEBD in fresh primary MEFs, and NEBD was
still observed to the same extent when TorsinA expression was
restored by stable transfection (not shown) indicating either that
the phenotype was unrelated to loss of TorsinA expression, or was
the result of a stable adaptation to loss of TorsinA.
Mechanism of NEBD
Regardless of its relationship to TorsinA expression we were
interested in the mechanism by which herpesvirus infection might
induce NEBD. We developed two assays for NEBD based on the
localization of the viral scaffold protein and capsid maturation
protease. The maturation protease and scaffold proteins VP21 and
VP22a (respectively) share an open reading frame and are recog-
nized by the same monoclonal antibody. The two proteins are
involved in capsid maturation and are normally highly concen-
trated inside the nucleus (Yang and Baines, 2008). We reasoned
that breaks in the NE, should result in relocalization of scaffold/
protease in the cytoplasm.
We ﬁrst used sub-cellular fractionation to determine whether
scaffold proteins become less concentrated in the nucleus in infected
Tor1a / MEFs. Nuclear and cytoplasmic fractions of mock- or HSV-1-
infected Tor1aþ /þ and Tor1a / MEFs were analyzed by immuno-
blotting for scaffold proteins, and for laminB, and alpha tubulin, which
mark the nuclear and cytoplasmic fractions, respectively (Fig. 3A).
As expected, more scaffold proteins accumulated in the nuclear than
in the cytoplasmic fraction in Tor1aþ /þ MEFs. The scaffold localization
was reversed in Tor1a / MEFs, in which most of the scaffold protein
accumulated in the cytoplasmic fraction. LaminB was conﬁned to the
nuclear fraction in all conditions because it is retained by association
with other lamina proteins. The presence of laminB only in the nuclear
fraction shows that the fractionation procedure effectively separated
nucleus and cytoplasm without contamination of the cytoplasmic
fraction. The presence of tubulin in the nuclear fraction however,
indicates some contamination with cytoplasmic fraction.
To quantify frequency of NEBD using scaffold protein localization,
Tor1aþ /þ and Tor1a/ MEFs were infected with HSV-1(F) and at
12 h.p.i. immunoﬂuorescently stained to detect scaffold and counter
stained for nuclei with TO-PRO-3. For each experiment, confocal
images of between 100 and 115 cells per cell line were taken.
Examples that show all of the scored localizations (not representative
ﬁelds) for Tor1aþ /þ and Tor1a / MEFs are shown in Fig. 3B. Scaffold
localizations received the following scores: “nucleus” – the scaffold
proteins were exclusively localized in the nucleus (examples are
indicated in Fig. 3B with white arrowheads); “mainly nucleus” –more
scaffold accumulated in the nucleus than in the cytoplasm (Fig. 3B
grey arrow); “cytoplasm” – the scaffold was distributed equally
between the nucleus and the cytoplasm or majority of the scaffold
accumulated in the cytoplasm (Fig. 3B white arrow). The scaffold was
found exclusively in the nucleus in vast majority (495%) of Tor1aþ /þ
MEFs, but in less than half of the Tor1a / MEFs (o41%). In three
independent experiments the standard deviation for scaffold localiza-
tion scores in Tor1aþ /þ and Tor1a/ MEFs was 5 and 15%, respec-
tively. Thus, in the majority of infected Tor1a/ cells, the otherwise
nuclear protein was also detected in the cytoplasm to varying degrees.
The apparent vesicularization of the NE during breakdown
suggested that virus-induced membrane fusion between the INM
and ONM might be responsible for NEBD. Accordingly, we deter-
mined whether gB, gH, and pUS3 expression were required.
We also tested importance of the primary envelopment machinery
in NE breakdown by determining whether there is a require-
ment for UL34 expression. Tor1aþ /þ and Tor1a/ MEFs were
infected with a BAC-derived HSV-1(F), or with BAC-derived HSV-1
(F) recombinant viruses with single deletions in gB (gB-null), gH
(gH-null) or double deletion in gB and gH (gB/gH-null). In addi-
tion, TA MEFs we also infected with HSV-1(F), vRR1072 (HSV-1
with deletion in UL34 gene), and vRR1202 (HSV-1 with deletion in
US3). The localization of scaffold proteins at 12 h.p.i. was analyzed
with confocal microscopy (Fig. 4). Less than 5% of Tor1aþ /þ MEFs
infected with any of the viruses showed cytoplasmic staining of
the scaffold. Tor1a / MEFs infected with HSV-1(F), BAC, gB-null
or gH-null infected Tor1a/ MEFs al showed relocalization of
scaffold with more than half of cells showing cytoplasmic staining
(scored as “mainly nucleus” and “cytoplasm”), indicating a high
rate of the NE breakdown. In Tor1a/ MEFs infected with gB/gH-
null or UL34-null, however, fewer cells showed cytoplasmic
scaffold localization in comparison to wild type virus. Notably,
there were about 5-fold fewer cells with considerable accumula-
tion of the scaffold in the cytoplasm (scored as ”cytoplasm”). These
results indicate that pUL34, gB and gH promote NE breakdown and
that gB and gH function in NE breakdown in redundant fashion.
On the other hand, more scaffold accumulated in the cytoplasm in
US3-null than in HSV-1(F) infected Tor1a / MEFs. In US3-null
infected Tor1a/ MEFs close to twice as many cells showed
cytoplasmic staining of scaffold compared to HSV-1(F), indicating
that pUS3 has an inhibitory effect on NE breakdown.
The similar effect of pUL34 and gB/gH deletions on NEBD suggests
the possibility that gB/gH deletion might alter the localization or
expression of pUL34. To test for change in localization, immunoﬂuor-
escent assays for pUL34 and for scaffolding protein were performed in
Tor1aþ /þ and / MEFs that were infected for 14 h with WT or
mutant BAC-derived viruses (Fig. 5A–D). pUL34 localization to the
nuclear envelope was relatively poor in Tor1aþ /þ cells infected with
wild-type virus (Fig. 5A). Although a distinct pUL34 nuclear rim could
be detected in about half of the cells, it was always accompanied by
extensive cytoplasmic staining and, in about half of the cells, concen-
tration at the nuclear rim could not be detected at all. pUL34
localization was similar in Tor1a / cells, except that pUL34 was
more often found in concentrations around the periphery of the
nucleus. Deletion of gB and gH together, did not alter the localization
of pUL34 in either Tor1aþ /þ or Tor1a / cells (Fig. 5C and D),
indicating that the diminished nuclear breakdown seen in the deletion
virus-infected cells was not due to mis-localization of pUL34. We also
determined the level of pUL34 and pUS3 expression in MEFs infected
with glycoprotein deletion viruses by immunoblotting of infected cell
lysates (Fig. 5E). The gB/gH null virus-infected cells reproducibly
showed a small decrease in pUL34 accumulation compared to wild-
type and the single deletion viruses, but expression was identical
between Tor1aþ /þ and Tor1a/ cells, indicating that the loss of NEBD
in gB/gH null infection was not due to loss of pUL34 expression.
Expression of pUS3 was also unchanged as a result of the gB/gH
deletion. Similarly, we tested to determine whether the inhibition of
NEBD in UL34-null infection might be due to alterations in gB or gH
expression, and found that gB and gH expression were unchanged in
UL34-null infected cells (Fig. 5E).
UL34-null virus replication is not rescued in Tor1a / MEFs
UL34-null virus is unable to undergo primary envelopment at the
INM and the virus titers in single-step growth are reduced three to
four log orders of magnitude (Chang et al., 1997; Fuchs et al., 2002;
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Klupp et al., 2000; Klupp et al., 2011; Roller et al., 2000; Ye and
Roizman, 2000). A phenotypic revertant of a UL34-null recombinant
of PrV (called ΔUL34Pass) was isolated following extensive passage
on non-complementing cells. This revertant caused NE disintegration
in infected cells (Klupp et al., 2011), indicating that NE breakdown
might provide another pathway for capsids to reach the cytoplasm
Fig. 3. Localization of the scaffold proteins. (A) Tor1aþ /þ and Tor1a / MEFs were mock or infected with HSV-1(F) at an MOI of 5 and 12 h later biochemically fractionated
into cytoplasmic (C) and nuclear (N) fractions, as described in the Material and methods section. Fractions were then analyzed by immunoblot with anti-scaffold antibody.
Blotting for laminB1 and alpha tubulin served an indicator for purity of nuclear and cytoplasmic fractions, respectively. (B) Tor1aþ /þ and Tor1a/ MEFs were infected with
HSV-1(F) at an m.o.i. of 5 and at 12 h.p.i visualized for scaffold proteins (red) and nucleus (blue). Scaffold localizations were scored as described in the text. The graph shown
is representative of three experiments with similar results.
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for ﬁnal maturation. Since the NE breakdown in UL34Pass infected
cells was very similar to what we observed in HSV-1(F) infected
Tor1a / MEFs, we asked if, in our system, NE disintegration would
provide a growth advantage for the UL34-null virus. As shown in
Fig. 4, UL34-null virus was still able to induce NE breakdown
although to a lesser extent that HSV-1(F).
To measure growth of UL34 deletion virus, Tor1aþ /þ and
Tor1a / MEFs were infected with HSV-1(F), vRR1072 and
vRR1072Rep (UL34-null repair virus) at an MOI of 5 and 16 h.p.i
virus titer were determined (Fig. 6). As expected, deletion of the
UL34 gene reduced virus titers about 1000-fold compared to WT
infection in Tor1aþ /þ cells. The UL34-null virus grew just as poorly
on the Tor1a / cells, indicating that NEBD provided no apparent
growth advantage.
Discussion
The NE breakdown in MEFs
Although the repertoire of HSV infected cell types that have
been examined by TEM is limited, there are no previous reports of
extensive NE breakdown in wild type virus infected cells. This can
be seen as surprising, given the extensive reorganization of
cellular components that are important for nuclear structure in
herpesvirus infected cells. Nuclear breakdown has now been
observed in two herpesvirus infection systems—the one described
here, and NEBD induced by UL31-null and UL34-null PrV variants.
This suggests that herpesviruses may walk a very ﬁne line that
ordinarily preserves the integrity of the NE, but allows capsid
access to the inner nuclear membrane and sufﬁcient ﬂexibility of
the NE to permit capsid envelopment.
That NEBD in response to wild type virus infection has only
been observed in transformed Tor1a/ MEFs and not in other
MEF cell lines, and the functional connection between TA and
Fig. 4. Viral products involved in the NE breakdown. Tor1a /and Tor1aþ /þ MEFs
were infected at an m.o.i. of 5 with viruses indicated on the bottom of the graphs
and at 12 h.p.i localization of scaffold proteins was analyzed with confocal
microscopy. The results were separated into two graphs for the ease of data
presentation. Data are representative of three independent experiments.
Fig. 5. Localization of pUL34 and expression of viral gene products in deletion
virus-infected cells. (A–D) Digital images of MEFs infected at an m.o.i. of 5 for 14 h
with WT or gB/gH-null viruses are shown. Cells were stained using primary
antibodies directed against scaffolding protein (red) and pUL34 (far red rendered
in blue). (E) Digital images of immunoblots of whole cell lysates of Tor1aþ /þ
(indicated with aþabove the lane) or Tor1a/ cells (indicated with aabove the
lane) that had been infected for 16 h with the indicated viruses at an m.o.i. of 5. The
protein probed for in each of the blots is shown to the left of each panel.
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nuclear envelope architecture suggest a connection with TA
expression. However, the observations that fresh, primary
Tor1a/ MEFs do not show NE breakdown, and that NE break-
down is not prevented by exogenous expression of TA indicate that
the connection is not simple, and are consistent with the possibi-
lity that NE breakdown is a peculiarity of this cell line unrelated to
the lack of TA expression. Tor1a / mice are not viable past
parturition (Goodchild et al., 2005). Although there are no obvious
cellular abnormalities in MEFs from Tor1a / embryos, it is
possible that subtle growth defects result in selection for com-
pensatory adaptations over the time required for transformation
and ampliﬁcation of this cell line, and that some stable adaptation
to TA deletion predisposes these cells to NE breakdown during
HSV infection. The nature of these adaptations is uncertain, but
since TorsinA is thought to be a molecular chaperone, it is possible
that changes in the expression or activity of other ER-resident
chaperones might compensate for TorsinA deﬁciency, and thereby
alter the activity of other cellular proteins involved in maintenance
of nuclear structure during HSV infection.
Mechanisms for the NE breakdown
The observation that two different herpesviruses can cause
extensive NE breakdown in some circumstances raises the ques-
tion of whether there is some conserved mechanism. Our results
suggest roles for both nuclear lamina disruption and membrane
fusion during infection-induced NE breakdown.
The nuclear lamina provides structural support, mechanical
stiffness and elasticity to the nuclear membrane (Burke and
Stewart, 2013). Not surprisingly, there is a strong correlation
between lamina and NE integrity. The lamina becomes disrupted
in instances of (i) NE breakdown during cell division, (ii) transient
NE ruptures in interphase cancer cells or cells from laminopathy
patients (De Vos et al., 2011; Vargas et al., 2012) and (iii) transient
NE breaks caused by parvovirus and HIV-1 infections (Cohen et al.,
2011; de Noronha et al., 2001). HSV-1 pUL34 and pUS3 are both
involved in lamina phosphorylation and reorganization (Bjerke
et al., 2003; Leach et al., 2007; Leach and Roller, 2010; Mou et al.,
2007; Park and Baines, 2006). UL34-null infection causes less
lamina disruption than infection with the wild-type virus (Bjerke
et al., 2003; Reynolds et al., 2004; Simpson-Holley et al., 2005).
This can be explained by failure of UL34-null virus to recruit PKCs
at the NE and possibly other kinases that phosphorylate lamina
(Leach and Roller, 2010; Park and Baines, 2006). In comparison to
HSV-1(F), infection with US3-null or US3-kinase dead mutant
viruses leads to exacerbated lamina disorganization (Bjerke and
Roller, 2006). While the mechanisms of this observation are
unknown, pUS3 might directly or indirectly increase the
activity of cellular/viral factors that mediate lamina disruption.
Thus, severity of predicted lamina disruption in UL34-null,
HSV-1(F) and US3-null viruses correlates with degree of NE
breakdown, suggesting that disruption of lamina organization
might help destabilize the NE, facilitating breakdown. This is
consistent with experiments with pharmacological inhibitors that
indicated that cellular factors that regulate the cell-cycle might be
important for the NE breakdown induced by PrV mutants (Grimm
et al., 2012). Speciﬁcally, CDK1 is an important contributor to
disruption of the lamina during mitosis, and the CDK inhibitor
Roscovitine inhibited the NE breakdown induced by ΔUL31Pass
and ΔUL34Pass (Grimm et al., 2012). US3 deletion may, however,
have multiple effects on NEBD, since it also phosphorylates pUL31,
and this phosphorylation is required for efﬁcient de-envelopment
fusion or virus release to the cytoplasm (Mou et al., 2009). If the
effect of US3-mediated pUL31 phosphorylation is to enhance de-
envelopment fusion, however, it is not clear how failure to
phosphorylate pUL31 might enhance NEBD.
The inhibition of NE breakdown seen in the double gB/gH
deletion infection suggests a role for membrane fusion. gB and gH
promote fusion of primary virions with the ONM (11). This
function is redundant, since single deletions have a much smaller
effect (for gB) or no effect (for gH). Furthermore, the function of gB
in de-envelopment is dependent upon residues important for its
intrinsic membrane fusion activity, and on its phosphorylation by
US3 (Wisner et al., 2009; Wright et al., 2009). In Tor1a / MEFs
the fusion-promoting activity of gB and gH could be misregulated,
leading to abnormal fusion events at the NE. This is consistent
with the apparent vesicularization of the nuclear envelope that
accompanied breakdown. While we cannot attribute this misre-
gulation to loss of torsin function, the cell-type dependence of NE
breakdown suggests that some cellular factors play a critical
regulatory role in regulation of membrane fusion at the nuclear
envelope during HSV infection.
The dependence on gB and gH function for NEBD seen here
contrasts with a recent report showing that single deletions of gB
or gH do not inhibit the NEBD induced by PrV variants ΔUL31Pass
and ΔUL34Pass (Schulz et al., 2013). This parallels a difference in
gB and gH function in de-envelopment fusion during capsid
nuclear egress—double deletions of gB and gH do not inhibit
de-envelopment fusion in PrV, but do inhibit in HSV infections
(Farnsworth et al., 2007; Klupp et al., 2008). This need not indicate
a fundamental difference in nuclear envelope fusion between the
two viruses. The double gB/gH deletion in HSV is only moderately
impaired for replication suggesting that there is an alternative, less
efﬁcient de-envelopment mechanism in play. It has been recently
reported that uninfected cells have an envelopment–de-envelop-
ment nuclear egress mechanism for RNP complexes (Speese et al.,
2012). It is possible that herpesviruses use both virus-speciﬁc and
hijacked cellular processes for membrane fusion at the NE with
different viruses using these alternative mechanisms to different
degrees.
NE breakdown and virus replication
In comparison to Tor1aþ /þ , about two thirds fewer capsids
accumulated in the nucleus of TA MEFs (Table 1), which might
entirely account for lower virus production in Tor1a/ MEFs.
Accumulation of viral products seemed to be unaffected by in the
absence of TA (Fig. 2), suggesting a defect in capsid stability and/or
formation. The relationship between NE integrity and capsid
production is not clear. One would expect that mixing the nuclear
and cytoplasmic content would have a negative effect on capsid
accumulation for two reasons. First, presence of cytoplasmic factor
(s) inside the nucleus might inhibit capsid assembly and/or
Fig. 6. Replication of UL34-null virus in TA MEFs. Tor1a/ and Tor1aþ /þ MEFs
were infected with the indicated viruses at an MOI of 5. At 16 h.p.i virus yields of
total culture were determined by a plaque assay on Vero cells for HSV-1(F) and
vRR1072 Rep or CX cells (Vero pUL34 complementing cell lines) for vRR1072. The
values plotted are averages of three separate experiments. Standard deviations are
indicated by error bars.
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stability and second, diffusion of nuclear products might results in
less efﬁcient capsid formation.
Although loss of UL34 expression resulted in diminished NEBD
in Tor1a / MEFs, about 40% of nuclei still showed evidence of
breakdown (Fig. 4). This NE breakdown did not signiﬁcantly
enhance replication of UL34-null virus (Fig. 6). If nuclear break-
down were completely sufﬁcient to suppress a nuclear egress
defect, we would have expected recovery of replication close to
what is seen for wild-type virus on the Tor1a / MEFs. That we
did not observe this result suggests that, at least for HSV, simply
allowing nucleocapsids access to the cytoplasm is insufﬁcient to
overcome loss of the normal primary envelopment pathway. This
may indicate that the UL34-dependent nuclear egress pathway
accomplishes more than simple transit of nucleocapsids to the
cytoplasm and may represent a maturation step. This contrasts
strongly with the normal replication phenotype of ΔUL31Pass and
ΔUL34Pass PrV (Klupp et al., 2011). While it is possible that
differences between HSV and PrV are at the root of this, it is also
possible that adaptations in the PrV mutants in addition to those
that induce NE breakdown may contribute strongly to their
growth efﬁciency.
Material and methods
Cells and viruses
Tor1a / and littermate Tor1aþ /þ mouse embryonic ﬁbroblast
(MEFs) were previously described (Kim et al., 2010). MEFs were
maintained in DMEM media supplemented with 15% FBS and Pen-
Strep. Vero and HEK 293 T cells were maintained as described
previously. An infection-inducible clonal Vero cell line that
expresses pUL34 (CX cells) was generated as previously described
(Roller et al., 2010). The properties of HSV-1(F), vRR1202 (HSV-1
(F) with deletion in US3 gene), vRR1072 (UL34-null virus) and its
repair viruses (vRR1072rep) were previously described and char-
acterized (Roller et al., 2000; Ryckman and Roller, 2004). Bacterial
artiﬁcial chromosome (BAC) containing the HSV-1(F) genome, BAC
with deletion in gB (gB-null), gH (gH-null) or double deletions in
gB and gH (gB/gH-null) were described previously (Farnsworth et
al., 2007). We refer to HSV-1(F) reconstituted from the BAC as
HSV-1(F)BAC to distinguish it from the non-recombinant HSV-1
(F) described by Ejercito et al. (1968).
Plasmids
C-terminally GFP-tagged wild type human TorsinA (GFP-TA)
and N-terminally myc-tagged mouse TorsinA (myc-TA) were a kind
gift from Phyllis Hanson, Washington University School of Medi-
cine, St. Louis (Naismith et al., 2004). pVETL vector expressing
CMV-promoter driven GFP and U6-promoter driven short hairpin
RNA (shRNA) targeting human and mouse TOR1A genes (shTA) or
nonsense gene (shcontrol) have been previously described
(Gonzalez-Alegre et al., 2005).
Viral growth assays
Replication of HSV-1(F), vRR1072 and vRR1072rep viruses on
MEFs was determined at MOI of 5. After allowing infection to
proceed for 1 h, the inoculum was removed and cells were washed
once brieﬂy with 1 ml of 50 mM Na Citrate, 4 mM KCl pH 3.0. After
removal of this ﬁrst wash, 1 ml of fresh low pH citrate buffer was
added and left on the cells for 1 min to inactivate residual virus.
The low pH buffer was removed and cells were washed twice with
cell growth medium and then maintained for the remainder of the
infection in their growth medium. Tor1aþ /þ and Tor1a / MEFs
were infected 12 h after plating to minimize the impact of
different generation times of the two cell lines. Virus yields
were determined by plaque assay on Vero (for HSV-1(F) and
pRR1072rep viruses) or CX cells (for vRR1072 virus) as described
(Roller et al., 2000). Statistical signiﬁcance p values were calcu-
lated using a two-tailed unpaired Student's t test.
Localization of HSV-1 scaffold protein
Cells were infected at an MOI of 5 and 12 h later were ﬁxed in
4% formaldehyde in PBS for 10 min, washed once in PBS and then
blocked and permeabilized by incubation in IF buffer (PBS contain-
ing 1% TritonX-100, 1% Sodium Deoxycholate, and 1% bovine
serum albumin) for at least 1 h. Primary anti-scaffold antibody
(AbD serotech, MCA406) was diluted 1:1000 in IF buffer Alexa-
Fluor conjugated secondary antibody (Invitrogen) was diluted
1:1000 in IF buffer. The nucleus was counterstained by incubating
the samples with TO-PRO-3 (Invitrogen) diluted 1:2000 in PBS for
15 min. SlowFade Antifade kit (Invitrogen) was used to mount
coverslips on glass slides. All images were obtained using a Zeiss
510 confocal microscope. Confocal images of up to 25 randomly
selected areas were taken. An area contained up to 15 cells. Cell
scoring is described below and the data are presented as percen-
tage of cells with each score.
Immunoﬂuorescence
Cells were infected at an MOI of 5 and 14 h later were ﬁxed and
stained for scaffold protein as described above, and for pUL34
using 1:1000 anti-UL34 antibody and 1:1000 AlexaFluor647
secondary antibody.
Transmission EM of infected cells
Conﬂuent monolayers of cells were infected with HSV-1(F) at a
multiplicity of ten for 20 h and then ﬁxed by incubation in 2.5%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 2 h. Cells
were post-ﬁxed in 1% osmium tetroxide, washed in cacodylate
buffer, embedded in Spurr's resin and cut into 95 nm sections.
Sections were mounted on grids, stained with uranyl acetate and
lead citrate and examined with a JEOL 1250 transmission electron
microscope.
Subcellular fractionation
Approximately 3106 MEFs were seeded in Petri dishes and
infected with mock or HSV-1(F) and an MOI of 5. At 12 h.p.i. cells
were scraped from the plates, washed one time with PBS, and
resuspended in 500 ml of buffer A (10 mM HEPES pH 7.5, 2 mM
MgCl2, 15 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, protease inhibitors
cocktail (Sigma, S8820)) for 15 min on ice. The suspension was
then gently mixed with 25 ml of 10% NP-40 and centrifuged at
7500 rpm for 5 min. The collected supernatant represented the
cytosolic fraction. The pellet was washed one time with buffer A
and then resuspended with 165 ml buffer C (25 mM HEPES pH 7.5,
400 mM NaCl, 1 mM EDTA, protease inhibitors cocktail) and
incubated for 30 min on ice with occasional mixing. The soluble
nuclear supernatant fraction was collected following centrifuga-
tion at 7500 rpm for 5 min.
Sample preparation for SDS-PAGE
To determine expression of viral proteins in MEFs, Tor1aþ /þ
and Tor1a/ MEFs were infected with HSV-1(F) at an MOI of
5 and at 12 h.p.i. cells were scraped, washed one time with PBS
and lysed in 1X SDS sample buffer (Thermo Scientiﬁc, 39001). To
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analyze accumulation of myc-TorsinA in stably expressing cell
lines, cells were scraped, washed one time in PBS and lysed in
lysis buffer (10 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA,
0.5% NP-40 with added protease inhibitors) on ice for 30 min. The
lysates were centrifuged at high speed and the supernatants were
then mixed with an equal volume of 2X SDS sample buffer. All SDS
containing samples were boiled and total protein concentration
was determined with BioRad Dc Protein Assay. β-mercaptoethanol
(Sigma) was added to samples before loading equal amounts of
protein on the SDS-PAGE.
Immunoblotting
After electrophoresis, proteins were transferred to nitrocellu-
lose membranes and membranes were then blocked overnight in
5% nonfat milk in T-TBS (10 mM NaCl, 20 mM Tris HCl and 0.05%
Tween 20). Primary antibodies were diluted in 5% nonfat milk in
T-TBS as follows: monoclonal anti-pUS11 (1:1000), chicken poly-
clonal antibody anti-pUL34 (1:1000) (Roller et al., 2000), rabbit
polyclonal anti-US3 (kind gift of Bernard Roizman) (1:500), mouse
monoclonal anti-gC (1:1000) (Virusys, H1A022), mouse monoclo-
nal anti-gD/DL6 (1:5000), mouse polyclonal anti-gB/SS55 (1:500)
(kindly provided by Gary H. Cohen and Roselyn J. Eisenberg,
University of Pennsylvania), monoclonal mouse anti-GAPDH
(1:1000) (Millipore, MAB374), monoclonal mouse anti-scaffold
(1:1000) (AbD serotech, MCA406), mouse anti-α-tubulin
(1:1000) (Li-COR, 926-42213), polyclonal rabbit anti-GFP (Invitro-
gen, A6455). Secondary alkaline phosphatase conjugated anti-
mouse (Sigma, A3562), anti-rabbit (Sigma, A3687) and anti-
chicken (Aves Lab, AP1001) antibodies were incubated with the
appropriate blot for 1 h.
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